Related Experiment Video
Updated: Jan 3, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.9K
Managing Paediatric Growth Disorders: Integrating Technology Into a Personalised Approach
Jenny Child1, Christine Davies2, Katie Frost3
1The Child Growth Foundation, Sutton Coldfield, UK
Journal of Clinical Research in Pediatric Endocrinology
|November 21, 2019
Summary
Managing growth hormone (GH) therapy requires strong patient-provider relationships and adherence. Digital tools and motivational interviewing can improve adherence and optimize growth outcomes for children.
Area of Science:
- Pediatric endocrinology
- Growth disorders management
- Patient adherence strategies
Background:
- Long-term growth management presents challenges for patients, families, and healthcare professionals (HCPs).
- Personalized growth hormone (GH) therapy response relies on a strong patient-family-HCP relationship.
- Unmet needs in growth management include identifying and managing poor growth response.
Purpose of the Study:
- To discuss current unmet needs in growth management.
- To emphasize the importance of adherence to GH therapy.
- To explore the role of digital tools and psychological techniques in improving adherence and outcomes.
Main Methods:
- Review of current challenges in growth management.
- Discussion of identification and management of poor growth response.
- Exploration of digital tools for adherence monitoring.
- Application of psychological techniques like motivational interviewing.
Main Results:
- Poor growth response likelihood and its management are key concerns.
- Digital tools can record injections and communicate adherence data.
- Psychological barriers to adherence can be addressed with specific techniques.
- Motivational interviewing enhances HCP-patient relationships and improves outcomes.
Conclusions:
- Personalized care, utilizing psychological skills by HCPs, is crucial for preventing and managing poor adherence.
- A human-eHealth partnership is essential to maximize the benefits of digital tools for successful growth management.
- Improving adherence through enhanced relationships and technology is vital for optimizing growth outcomes.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
206
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
01:10Nature and Nurture
22.1K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.1K
01:29Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
177
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
156
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156